The pharmaceutical distributor has launched InspiroGene, a business unit offering logistics and other support for ...

In October 2024, the Company requested Breakthrough Therapy designation and Qualified Infectious ... in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). SER-155 has ...

Thanks to Joanna from Poland, I have no measurable leukemia. Getting college-age kids to join the bone-marrow donor registry ...

The Love Hope Strength Foundation (LHS), established by The Alarm rock band’s frontman Mike Peters (65), and his wife Jules ...

Initial Clinical Data from Phase 1 Autoimmunity Study of FT819 1XX CAR T-cell Product Candidate to be Presented in 4Q24; Second Treatment Arm ...

A research team has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with small cell bladder cancer and small cell ...

AstroRx is a cell-based therapy designed to compensate for the malfunctioning of astrocytes in ALS, which should help prevent ...

For the quarter ended September 30, 2024, the Company had a loss from operations of $2.3 million, a 26% year-over-year improvement from $3.1 million for the comparable period of 2023, and a 9% ...

Six main cell types form glioblastomas (GBM), the most aggressive brain cancer due to its high rate of recurrence. Of these six, quiescent cancer stem cells are responsible for resistance to therapy ...

PHAT is a facial rejuvenation therapy that combines nanofat and its stem cells with PRP for anti-aging that lasts for more ...

Robert F. Kennedy Jr., one of President-elect Donald J. Trump’s advisers on health, is taking aim at the agency’s oversight ...